Advertisement

Uncategorized

Advertisement

Following the passage of House Bill 1 last week, some pain physicians are questioning the necessity and logistics behind the bill's requirement that physicians consult the state's online drug database, KASPER, prior to prescribing pain medication to a patient, according…

A new drug developed by Tel Aviv University researchers has been licensed by pharmaceutical company BioLineRx and offers a new treatment option to patients with neuropathic pain.

The American Hospital Association has expressed concern over elements of the proposed rule for Stage 2 meaningful use, stating the rules "would stand in the way of a successful program to support widespread adoption by all hospitals."

Advertisement